Cart is empty
View Cart
Subtotal: $0.00
JOIN NOW!
Featured Image

Governor Healey Proposes Major Initiatives in Life Sciences

  • Posted by ISPE Boston
  • On March 7, 2024
Governor Healey has announced that she is reauthorizing the Life Sciences Initiative that has made Massachusetts a global leader in life sciences. The initiative proposes reauthorizing the Life Sciences Initiative at $1 billion for 10 years and will be included in the administration’s upcoming economic development bill, called the Mass Leads Act, which will require passage […]
Read More
 
 Featured Image

Chapter Member Anniversaries: March 2024

  • Posted by ISPE Boston
  • On March 4, 2024
Please congratulate the following members celebrating milestone anniversaries in March 2024.  Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Anubhav Bhargava, Skanska USA Building Inc Andrew Collentro Charles Cooney, MIT Chemical Engineering Brian Duffy, Integrated Project Services Eric Felz Brian Hagopian, Clear Water Consulting, Inc. David Harney, […]
Read More
 
 Featured Image

Welcome New Members February 2024

  • Posted by ISPE Boston
  • On March 4, 2024
We would like to introduce the Members who joined ISPE in February 2024, welcome them to the Chapter, and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]
Read More
 
 Featured Image

SOLD OUT at Tome Biosciences Event at Arsenal on the Charles in Watertown, MA

  • Posted by Kelly Doering
  • On February 20, 2024
First of all – have you been to the Arsenal on the Charles Life Sciences complex? It is a gorgeous hub of activity amidst ongoing new construction and renovation of historical brick buildings that, as the name suggests, were once dedicated to the military. On February 15th, the ISPE Boston Chapter’s Educational Program Committee (EPC) […]
Read More
 
 Featured Image

Call for Nominations for the ISPE Board of Directors!

  • Posted by ISPE Boston
  • On February 13, 2024
Do you know a member of ISPE Boston who would be well-suited to serve on the ISPE Boston Area Chapter Board of Directors? The Nominating Committee is looking for your help to identify members within the Chapter who would be well-suited to serve on the 2024-2025 ISPE Boston Area Chapter Board of Directors. In an […]
Read More
 
 Featured Image

Join the Ride to End ALZ New England on June 1

  • Posted by ISPE Boston
  • On February 12, 2024
Join the 28th annual Ride to End ALZ New England, a fully supported, one-day fundraising event at the beach offering 14 miles of coastal riding. Whether you’re a dedicated cyclist or a casual rider, the Ride to End ALZ® New England provides a picturesque New England route suitable for all. Every mile you ride will […]
Read More
 
 Featured Image

A Full House at the Student Career Workshop

  • Posted by ISPE Boston
  • On February 9, 2024
On Saturday, February 3rd, local biopharma students gathered for the annual Student Career Workshop. The day kicked off with icebreakers and interview questions with Dave Novak (IPS), a Past-President of ISPE, followed by a panel discussion about Roles in Pharma and Biotech with Industry Leaders Sharad Sharma (Sanofi), Sean Keenan (Moderna), Jeff Kelly (Blue Ocean […]
Read More
 
 Featured Image

Biogen Drops Alzheimer’s Drug Aduhelm

  • Posted by ISPE Boston
  • On February 8, 2024
Biogen has announced plans to reprioritize its resources in Alzheimer’s disease, a strategic therapeutic area expected to drive near and long-term growth. The company will continue to advance Leqembi, the first anti-amyloid beta treatment with FDA traditional approval in the United States, and will accelerate development of potential new treatment modalities, including its ASO targeting […]
Read More
 
 Featured Image

Vertex Painkiller Making Progress

  • Posted by ISPE Boston
  • On February 8, 2024
Vertex has announced positive results from its Phase 3 program in the treatment of moderate-to-severe acute pain using its selective NaV1.8 inhibitor called VX-548. NaV1.8 plays a critical role in pain signaling in the peripheral nervous system. Vertex’s approach is to selectively inhibit NaV1.8 using small molecules with the objective of creating a new class […]
Read More
 
 Featured Image

Chapter Member Anniversaries: February 2024

  • Posted by ISPE Boston
  • On February 5, 2024
Please congratulate the following members celebrating milestone anniversaries in February 2024.  Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years John P. Alleruzzo Christopher E. Ames, EQRx James M. Crotty, MSFM, Continuus Pharmaceuticals Dr. Eric S. Good, ProPharma Group David E. Greenberg, Saint-Gobain Life Sciences John L. Gunst, […]
Read More